Year Founded
2014
Ownership
Private
Stage
Commercial
Modalities
Large moleculeProtein therapeuticsBioengineered tissue

LinkoCare General Information

Developing bioengineered corneal implants for treating corneal blindness and vision impairment. Only producer of clinically tested bioengineered corneal implants worldwide.

Contact Information

Website
Primary Industry
Medical Device
Corporate Office
Stockholm, Solna
Sweden

Drug Pipeline

Bioengineered full-thickness corneal implant
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to LinkoCare's pipeline data

Book a demo

Key Partnerships

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

LinkoCare Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view LinkoCare's complete valuation and funding history, request access »

LinkoCare Investors

European Union Horizon2020 Program (grant/funding support)
Investor Type: Venture Capital
Holding: Minority
ALF funds from Linköping University and Östergötland Region(grant/funding support)
Investor Type: Venture Capital
Holding: Minority